findmyKOL

Talal Alnabelsi, MD

Basic profile

Investigators Research Group

ORCIDNPI
RegionLexington, KY · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Talal Alnabelsi is a Cardiology physician affiliated with Investigators Research Group. OpenAlex indexes 87 publications with 500 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
87publications

Distinct works indexed by OpenAlex, matched via ORCID.

500citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

800 Rose St
Lexington, KY 40536

Telephone

859-323-0295

Provider last certified this registry record 23 Jul 2021.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.2%
    Beta blocker18.1%
    Metoprolol Succinate49%Carvedilol32%Metoprolol Tartrate19%
    Part D40 patients
    Statin14.7%
    Atorvastatin Calcium51%Rosuvastatin Calcium49%
    Part D38 patients

    + 12 more classes in this area

  • Blood & clotting

    15.6%
    Factor Xa inhibitor11.5%
    Eliquis86%Xarelto14%
    Part D<11 patients
    P2Y12 inhibitor2.6%
    Clopidogrel100%
    Part D13 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    9.2%
    SGLT2 inhibitor7.2%
    Jardiance75%Farxiga26%
    Part D<11 patients
    Proton pump inhibitor2.1%
    Pantoprazole Sodium100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”